TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Comparative Acceptability, Safety, Effects and Expense of Specialized, Integrated, and Interdisciplinary Community Rehabilitation for Stroke Survivors and Their Caregivers
Brief Summary: As the population ages and the number of stroke survivors increases, information is needed to determine the best way of providing home care services for rehabilitation to stroke survivors and their caregivers while containing health care costs. This project will address this area by developing and testing the effects and costs of a collaborative and specialized team approach to stroke rehabilitation by health professionals, in a home care setting, compared to usual home care services. The overall goal of this way of providing home care services is to improve the quality of life and function of stroke survivors and their caregivers and prevent future strokes, which will reduce the overall cost to the health care system.


Options:
A: Arm Label: Memory Training Program; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Healthy Lifestyle Training Program; Type: EXPERIMENTAL; Interventions: Behavioral: Healthy Lifestyle Training Program | Intervention Type: BEHAVIORAL; Name: Healthy Lifestyle Training Program; Assigned to Arm(s): Healthy Lifestyle Training Program
B: Arm Label: Peer-Led Stroke Recurrence Prevention Education; Type: EXPERIMENTAL; Interventions: Behavioral: Prevent Return of Stroke | Arm Label: Usual Care (Delayed Intervention); Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Prevent Return of Stroke | Intervention Type: BEHAVIORAL; Name: Prevent Return of Stroke; Assigned to Arm(s): Peer-Led Stroke Recurrence Prevention Education | Intervention Type: BEHAVIORAL; Name: Prevent Return of Stroke; Assigned to Arm(s): Usual Care (Delayed Intervention)
C: Arm Label: Interprofessional Team Approach; Type: EXPERIMENTAL; Interventions: Other: Interprofessional Team Approach | Arm Label: Usual Home Care Services; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Interprofessional Team Approach; Assigned to Arm(s): Interprofessional Team Approach
D: Arm Label: Intervention for diet, exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Educational intervention for diet and physical activity | Arm Label: Control; Type: OTHER; Interventions: Behavioral: Educational message on skin cancer awareness | Intervention Type: BEHAVIORAL; Name: Educational intervention for diet and physical activity; Assigned to Arm(s): Intervention for diet, exercise | Intervention Type: BEHAVIORAL; Name: Educational message on skin cancer awareness; Assigned to Arm(s): Control

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Comparative Acceptability, Safety, Effects and Expense of Specialized, Integrated, and Interdisciplinary Community Rehabilitation for Stroke Survivors and Their Caregivers
Brief Summary: As the population ages and the number of stroke survivors increases, information is needed to determine the best way of providing home care services for rehabilitation to stroke survivors and their caregivers while containing health care costs. This project will address this area by developing and testing the effects and costs of a collaborative and specialized team approach to stroke rehabilitation by health professionals, in a home care setting, compared to usual home care services. The overall goal of this way of providing home care services is to improve the quality of life and function of stroke survivors and their caregivers and prevent future strokes, which will reduce the overall cost to the health care system.


Options:
A: Arm Label: Motivation and lifestyle intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Motivation and lifestyle intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Motivation and lifestyle intervention; Assigned to Arm(s): Motivation and lifestyle intervention
B: Arm Label: CO-OP; Type: EXPERIMENTAL; Interventions: Behavioral: CO-OP | Arm Label: Standard Occupational Therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard Occupational Therapy | Intervention Type: BEHAVIORAL; Name: CO-OP; Assigned to Arm(s): CO-OP | Intervention Type: BEHAVIORAL; Name: Standard Occupational Therapy; Assigned to Arm(s): Standard Occupational Therapy
C: Arm Label: Cognitive-Oriented Strategy Augmented Rehabilitation (COSTAR); Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive-Oriented Strategy Augmented Rehabilitation (COSTAR) | Arm Label: Task Specific Training (TST); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Task Specific Training (TST) | Intervention Type: BEHAVIORAL; Name: Cognitive-Oriented Strategy Augmented Rehabilitation (COSTAR); Assigned to Arm(s): Cognitive-Oriented Strategy Augmented Rehabilitation (COSTAR) | Intervention Type: BEHAVIORAL; Name: Task Specific Training (TST); Assigned to Arm(s): Task Specific Training (TST)
D: Arm Label: Interprofessional Team Approach; Type: EXPERIMENTAL; Interventions: Other: Interprofessional Team Approach | Arm Label: Usual Home Care Services; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Interprofessional Team Approach; Assigned to Arm(s): Interprofessional Team Approach

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: CABG Off or On Pump Revascularization Study (CORONARY)
Brief Summary: I. Main Research Question:

* To compare the risks and benefits of Off-pump Coronary artery bypass surgery (CABG) to On-pump CABG and to determine if one is better than the other.
* The purpose of this pilot study is also to see the rate of recruitment with expertise-based randomization across different hospital settings.

II. Small RCT studies and meta-analyses done so far have not been able to conclusively say which of the procedure is better. A large randomized study is required to establish the risks and benefits associated with both the off-pump and on-pump CABG surgical procedures.

III. The study will look at which of the two techniques reduce major risks associated with CABG.


Options:
A: Arm Label: Atorvastatin, Ischemic Heart Disease; Type: OTHER; Interventions: Drug: Atorvastatin, high vs low dose | Arm Label: Atorvastatin vs Placebo Cardiac Surgery; Type: PLACEBO_COMPARATOR; Interventions: Drug: Atorvastatin vs Placebo | Intervention Type: DRUG; Name: Atorvastatin, high vs low dose; Assigned to Arm(s): Atorvastatin, Ischemic Heart Disease | Intervention Type: DRUG; Name: Atorvastatin vs Placebo; Assigned to Arm(s): Atorvastatin vs Placebo Cardiac Surgery
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: atorvastatin | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: atorvastatin; Assigned to Arm(s): 1
C: Arm Label: On Pump Arm; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Coronary Artery Bypass Graft with the use of CPB | Arm Label: Off Pump Arm; Type: EXPERIMENTAL; Interventions: Procedure: Coronary Artery Bypass Graft without the use of CPB | Intervention Type: PROCEDURE; Name: Coronary Artery Bypass Graft with the use of CPB; Assigned to Arm(s): On Pump Arm | Intervention Type: PROCEDURE; Name: Coronary Artery Bypass Graft without the use of CPB; Assigned to Arm(s): Off Pump Arm
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Atorvastatin | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Atorvastatin; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A 12-week, Multicenter, Randomized, Double-Blind, Parallel-Group Study of the Combination of ABT-335 and Rosuvastatin Compared to ABT-335 and Rosuvastatin Monotherapy in Subjects With Type IIa and IIb Dyslipidemia
Brief Summary: The purpose of this study is to evaluate the safety and efficacy of ABT-335 and rosuvastatin calcium combination therapy to monotherapy in subjects with dyslipidemia.


Options:
A: Arm Label: ABT-335 plus rosuvastatin; Type: EXPERIMENTAL; Interventions: Drug: ABT-335 plus rosuvastatin | Arm Label: Rosuvastatin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Rosuvastatin | Intervention Type: DRUG; Name: ABT-335 plus rosuvastatin; Assigned to Arm(s): ABT-335 plus rosuvastatin | Intervention Type: DRUG; Name: Rosuvastatin; Assigned to Arm(s): Rosuvastatin
B: Arm Label: ABT-335 and Rosuvastatin Calcium; Type: EXPERIMENTAL; Interventions: Drug: ABT-335 and rosuvastatin calcium | Arm Label: ABT-335; Type: ACTIVE_COMPARATOR; Interventions: Drug: ABT-335 | Arm Label: Rosuvastatin Calcium; Type: ACTIVE_COMPARATOR; Interventions: Drug: rosuvastatin calcium | Intervention Type: DRUG; Name: ABT-335 and rosuvastatin calcium; Assigned to Arm(s): ABT-335 and Rosuvastatin Calcium | Intervention Type: DRUG; Name: ABT-335; Assigned to Arm(s): ABT-335 | Intervention Type: DRUG; Name: rosuvastatin calcium; Assigned to Arm(s): Rosuvastatin Calcium
C: Intervention Type: DRUG; Name: Rosuvastatin (Crestor); Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Ezetimibe; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Simvastatin; Assigned to Arm(s): N/A
D: Arm Label: rosuva 5; Type: ACTIVE_COMPARATOR; Interventions: Drug: Rosuvastatin | Arm Label: rosuva 10; Type: ACTIVE_COMPARATOR; Interventions: Drug: Rosuvastatin | Arm Label: rosuva 20; Type: ACTIVE_COMPARATOR; Interventions: Drug: Rosuvastatin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: rosuva ol; Type: OTHER; Interventions: Drug: Rosuvastatin | Intervention Type: DRUG; Name: Rosuvastatin; Assigned to Arm(s): rosuva 10, rosuva 20, rosuva 5, rosuva ol | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Comparative Effects and Expenses of a Proactive Nurse-Led, Multifactorial and Interdisciplinary Team Approach to Falls Prevention for Older At-Risk Home Care Clients
Brief Summary: With an aging population, an associated increase in the number of falls and fall injuries, there is a need to examine how health care services, such as home care, can best prevent falls among older people. This project will directly address this area by evaluating the effects and expense of an innovative approach to home care service delivery for older people at-risk for falls.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Falls Prevention | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Falls Prevention; Assigned to Arm(s): 1
B: Arm Label: observational; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Exercise group; Type: EXPERIMENTAL; Interventions: Other: Exercise intervention | Intervention Type: OTHER; Name: Exercise intervention; Assigned to Arm(s): Exercise group
C: Arm Label: Home-based Exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Home-based exercise | Arm Label: Education; Type: EXPERIMENTAL; Interventions: Behavioral: Education | Arm Label: Exercise plus education; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise plus Education | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Home-based exercise; Assigned to Arm(s): Home-based Exercise | Intervention Type: BEHAVIORAL; Name: Education; Assigned to Arm(s): Education | Intervention Type: BEHAVIORAL; Name: Exercise plus Education; Assigned to Arm(s): Exercise plus education
D: Arm Label: Multifactorial intervention; Type: EXPERIMENTAL; Interventions: Device: multifactorial | Intervention Type: DEVICE; Name: multifactorial; Assigned to Arm(s): Multifactorial intervention

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Comparative Effects and Expenses of a Proactive Nurse-Led, Multifactorial and Interdisciplinary Team Approach to Falls Prevention for Older At-Risk Home Care Clients
Brief Summary: With an aging population, an associated increase in the number of falls and fall injuries, there is a need to examine how health care services, such as home care, can best prevent falls among older people. This project will directly address this area by evaluating the effects and expense of an innovative approach to home care service delivery for older people at-risk for falls.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Falls Prevention | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Falls Prevention; Assigned to Arm(s): 1
B: Arm Label: physical activity and nutrition; Type: EXPERIMENTAL; Interventions: Behavioral: Project Fit | Intervention Type: BEHAVIORAL; Name: Project Fit; Assigned to Arm(s): physical activity and nutrition
C: Arm Label: Standard care; Type: EXPERIMENTAL; Interventions: Behavioral: Assertive Community Treatment (ACT) | Intervention Type: BEHAVIORAL; Name: Assertive Community Treatment (ACT); Assigned to Arm(s): Standard care
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: interdisciplinary intervention or meeting-seminars | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: interdisciplinary intervention or meeting-seminars | Intervention Type: BEHAVIORAL; Name: interdisciplinary intervention or meeting-seminars; Assigned to Arm(s): 1, 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Magnesium Sulfate Versus Placebo for Tocolysis in Preterm Premature Rupture of Membranes
Brief Summary: Study compares the outcomes of women between 26 and 32 wks gestation with rupture of membranes. Women randomized to receive tocolysis with magnesium sulfate x 48 hrs or placebo of saline IV x 48 hrs. Antibiotics and antenatal steroids given to both groups.


Options:
A: Arm Label: Magnesium sulphate; Type: EXPERIMENTAL; Interventions: Drug: Magnesium Sulfate | Arm Label: Ritodrine; Type: EXPERIMENTAL; Interventions: Drug: Ritodrine | Arm Label: Calcium channel blocker; Type: EXPERIMENTAL; Interventions: Drug: Calcium Channel Blockers | Intervention Type: DRUG; Name: Magnesium Sulfate; Assigned to Arm(s): Magnesium sulphate | Intervention Type: DRUG; Name: Ritodrine; Assigned to Arm(s): Ritodrine | Intervention Type: DRUG; Name: Calcium Channel Blockers; Assigned to Arm(s): Calcium channel blocker
B: Arm Label: Indomethacin group; Type: EXPERIMENTAL; Interventions: Drug: Indomethacin | Arm Label: Nifedipine group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nifedipine | Intervention Type: DRUG; Name: Indomethacin; Assigned to Arm(s): Indomethacin group | Intervention Type: DRUG; Name: Nifedipine; Assigned to Arm(s): Nifedipine group
C: Intervention Type: DRUG; Name: Indomethacin; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Magnesium sulfate; Assigned to Arm(s): N/A
D: Arm Label: Magnesium sulfate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Magnesium sulfate | Arm Label: Normal saline; Type: PLACEBO_COMPARATOR; Interventions: Drug: Magnesium sulfate | Intervention Type: DRUG; Name: Magnesium sulfate; Assigned to Arm(s): Magnesium sulfate, Normal saline

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Topiramate for Treatment of Patients With Borderline Personality Disorder and Alcohol Dependence
Brief Summary: The objective of the present study is to evaluate the efficacy of topiramate (250mg/day) versus placebo in decreasing aggression and reducing alcohol consumption in patients with borderline personality disorder (BPD) and alcohol dependence (AD).


Options:
A: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: General Psychiatric Management | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Dialectical Behaviour Therapy | Intervention Type: BEHAVIORAL; Name: General Psychiatric Management; Assigned to Arm(s): A | Intervention Type: BEHAVIORAL; Name: Dialectical Behaviour Therapy; Assigned to Arm(s): 2
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: quetiapine extended-release | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: quetiapine extended-release | Arm Label: 3; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: quetiapine extended-release; Assigned to Arm(s): 1, 2 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 3
C: Intervention Type: DRUG; Name: Topiramate; Assigned to Arm(s): N/A
D: Arm Label: Dialectical behavior therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Dialectical behavior therapy (DBT) | Arm Label: alternative psychotherapy; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Dialectical behavior therapy (DBT) | Intervention Type: BEHAVIORAL; Name: Dialectical behavior therapy (DBT); Assigned to Arm(s): Dialectical behavior therapy, alternative psychotherapy

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Topiramate for Treatment of Patients With Borderline Personality Disorder and Alcohol Dependence
Brief Summary: The objective of the present study is to evaluate the efficacy of topiramate (250mg/day) versus placebo in decreasing aggression and reducing alcohol consumption in patients with borderline personality disorder (BPD) and alcohol dependence (AD).


Options:
A: Arm Label: Group 1; Type: EXPERIMENTAL; Interventions: Device: Active tDCS, Device: Sham tDCS | Arm Label: Group 2; Type: EXPERIMENTAL; Interventions: Device: Active tDCS, Device: Sham tDCS | Intervention Type: DEVICE; Name: Active tDCS; Assigned to Arm(s): Group 1, Group 2 | Intervention Type: DEVICE; Name: Sham tDCS; Assigned to Arm(s): Group 1, Group 2
B: Arm Label: SB-APP Psychotherapy; Type: EXPERIMENTAL; Interventions: Other: SB-APP | Arm Label: TAU treatment; Type: ACTIVE_COMPARATOR; Interventions: Other: treatment as usual | Intervention Type: OTHER; Name: SB-APP; Assigned to Arm(s): SB-APP Psychotherapy | Intervention Type: OTHER; Name: treatment as usual; Assigned to Arm(s): TAU treatment
C: Arm Label: Non-Education; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Non-Education | Arm Label: Education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Education | Intervention Type: BEHAVIORAL; Name: Education; Assigned to Arm(s): Education | Intervention Type: BEHAVIORAL; Name: Non-Education; Assigned to Arm(s): Non-Education
D: Intervention Type: DRUG; Name: Topiramate; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Phase II Trial With Cetuximab and Cisplatin in the Treatment of ER-negative, PgR-negative, HER2-negative Metastatic Breast Carcinoma ("Basal Like")
Brief Summary: The primary objective of this study is to determine whether overall response to cetuximab combined with cisplatin is better than overall response to cisplatin alone together with showing that the overall response for cetuximab and cisplatin was above a pre-specified threshold of 0.2 in the treatment of "triple negative" metastatic breast cancer.

The secondary objective of this study is to compare the differences between the two treatment groups using the following criteria : Progression-Free Survival (PFS) Time, Overall Survival (OS), Time to Response (TTR) and Safety.


Options:
A: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Drug: AZ2281 + Carboplatin | Arm Label: Arm 2; Type: EXPERIMENTAL; Interventions: Drug: AZ2281 + Carboplatin | Intervention Type: DRUG; Name: AZ2281 + Carboplatin; Assigned to Arm(s): Arm 1, Arm 2
B: Arm Label: Gemcitabine,cisplatin; Type: EXPERIMENTAL; Interventions: Drug: Gemcitabine,cisplatin | Arm Label: Gemcitabine, Paclitaxel; Type: ACTIVE_COMPARATOR; Interventions: Drug: Gemcitabine, Paclitaxel | Intervention Type: DRUG; Name: Gemcitabine,cisplatin; Assigned to Arm(s): Gemcitabine,cisplatin | Intervention Type: DRUG; Name: Gemcitabine, Paclitaxel; Assigned to Arm(s): Gemcitabine, Paclitaxel
C: Intervention Type: DRUG; Name: AZD 2281; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Cisplatin; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Gemcitabine; Assigned to Arm(s): N/A
D: Arm Label: cisplatin and cetuximab; Type: EXPERIMENTAL; Interventions: Drug: cetuximab, cisplatin | Arm Label: cisplatin; Type: ACTIVE_COMPARATOR; Interventions: Drug: cisplatin | Intervention Type: DRUG; Name: cetuximab, cisplatin; Assigned to Arm(s): cisplatin and cetuximab | Intervention Type: DRUG; Name: cisplatin; Assigned to Arm(s): cisplatin

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The purpose of this study is to evaluate the effect of two different maintenance doses of Symbicort Maintenance And Reliever Therapy (SMART) in adult asthmatic patients. A 6 month treatment period


Options:
A: Intervention Type: DRUG; Name: Budesonide/formoterol; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: Budesonide/formoterol Turbuhaler; Assigned to Arm(s): N/A
C: Intervention Type: DRUG; Name: beclomethasone/salbutamol combination; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: beclomethasone; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: salbutamol; Assigned to Arm(s): N/A
D: Intervention Type: DRUG; Name: Budesonide/formoterol Turbuhaler; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Salmeterol/fluticasone Diskus; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The purpose of this study is to evaluate the effect of two different maintenance doses of Symbicort Maintenance And Reliever Therapy (SMART) in adult asthmatic patients. A 6 month treatment period


Options:
A: Intervention Type: DRUG; Name: Budesonide/formoterol Turbuhaler; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: Budesonide/formoterol; Assigned to Arm(s): N/A
C: Intervention Type: DRUG; Name: budesonide/formoterol Turbuhaler; Assigned to Arm(s): N/A
D: Intervention Type: DRUG; Name: Budesonide/formoterol Turbuhaler; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Salmeterol/fluticasone Diskus; Assigned to Arm(s): N/A

Answer: B